Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

AIDS (London, England) - 1 Sept 1997

Meyer L, Magierowska M, Hubert J B, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy J F, Theodorou I

Abstract excerpt

OBJECTIVE: To determine the influence of heterozygosity for the delta 32 mutant CCR-5 allele on HIV-1 disease progression. DESIGN: HIV-1 disease progression and serum viral load were analysed according to the C-C chemokine receptor (CCR)-5 genotype in 412 Caucasian patients (319 men and 93 women)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Alleles
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Risk Factors

Share to RNA, Viral

Share to Sex Factors

Source

Identifiers

PMID: 9302436
DOI: 10.1097/00002030-199711000-00001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-9302436-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.PMID 9302436Read ↗

Association between CCR5 genotype and the clinical course of HIV-1 infection.Semantic proximity Read ↗

Causal pathways for CCR5 genotype and HIV progression.Semantic proximity Read ↗

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.Semantic proximity Read ↗

Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.Semantic proximity Read ↗

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individualsSemantic proximity Read ↗

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.Semantic proximity Read ↗

HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.Semantic proximity Read ↗

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).Semantic proximity Read ↗

MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.Semantic proximity Read ↗

CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.Semantic proximity Read ↗

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.Semantic proximity Read ↗

Association between a defective CCR-5 gene and progression to disease in HIV infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.